Glycerin 2000 MG Rectal Suppository — RxCUI 104155
RxNorm drug concept · Semantic clinical drug
RxCUI 104155
Semantic clinical drug · SCD
● Current RxNorm concept 20 FDA products
39 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI104155
Official nameGlycerin 2000 MG Rectal Suppository
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asglycerin 2 GM Rectal Suppository
FDA products mapped20
Package NDCs mapped39
Reported Medicaid activity (SDUD)1,573 prescriptions · 11 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How Glycerin 2000 MG Rectal Suppository Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Glycerin 2000 MG Rectal Suppository
RxCUI 104155 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Glycerin
4910IN
-
Glycerin
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Glycerin Rectal Suppository
372337SCDF -
Glycerin Rectal Product
1156856SCDG -
Rectal Suppository
316978DF -
Rectal Product
1151127DFG
-
Glycerin Rectal Suppository
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Glycerin 2000 MG
360509SCDC
-
Glycerin 2000 MG
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Glycerin 2000 MG
SCDC · 360509 -
Glycerin Rectal Suppository
SCDF · 372337 -
Glycerin Rectal Product
SCDG · 1156856
📦 FDA Products & Package NDCs
20 products · 39 package NDCs
39 package NDCs map to RxCUI 104155 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00132-0075-00 | 100 SUPPOSITORY in 1 JAR (0132-0075-00) | Fleet | C.B. Fleet Company, Inc. | 1984-11-01 |
| 00132-0075-12 | 12 SUPPOSITORY in 1 JAR (0132-0075-12) | Fleet | C.B. Fleet Company, Inc. | 1984-11-01 |
| 00132-0075-24 | 24 SUPPOSITORY in 1 JAR (0132-0075-24) | Fleet | C.B. Fleet Company, Inc. | 1984-11-01 |
| 00132-0075-50 | 50 SUPPOSITORY in 1 JAR (0132-0075-50) | Fleet | C.B. Fleet Company, Inc. | 1984-11-01 |
| 00363-0445-00 | 100 SUPPOSITORY in 1 JAR (0363-0445-00) | Walgreens Adult Glycerin Laxative | Walgreens | 2020-10-28 |
| 00363-0445-21 | 10 BLISTER PACK in 1 CARTON (0363-0445-21) / 10 SUPPOSITORY... | Walgreens Adult Glycerin Laxative | Walgreens | 2026-05-26 |
| 00363-0445-22 | 5 BLISTER PACK in 1 CARTON (0363-0445-22) / 5 SUPPOSITORY i... | Walgreens Adult Glycerin Laxative | Walgreens | 2026-05-26 |
| 00363-0445-25 | 25 SUPPOSITORY in 1 JAR (0363-0445-25) | Walgreens Adult Glycerin Laxative | Walgreens | 2016-11-01 |
| 11822-3312-05 | 50 SUPPOSITORY in 1 JAR (11822-3312-5) | Glycerin | Rite Aid Corporation | 2011-10-14 |
| 11822-3312-09 | 100 SUPPOSITORY in 1 JAR (11822-3312-9) | Glycerin | Rite Aid Corporation | 2011-10-14 |
| 11822-9100-00 | 100 SUPPOSITORY in 1 JAR (11822-9100-0) | Rite-Aid Glycerin Laxative | RITE AID CORPORATION | 2024-01-01 |
| 11822-9100-05 | 50 SUPPOSITORY in 1 JAR (11822-9100-5) | Rite-Aid Glycerin Laxative | RITE AID CORPORATION | 2024-01-01 |
| 13709-0322-01 | 25 CAPSULE in 1 JAR (13709-322-01) / 1 SUPPOSITORY in 1 CAP... | Glycerin Laxative | NeilMed Pharmaceuticals Inc. | 2023-08-24 |
| 13709-0329-01 | 30 BLISTER PACK in 1 CARTON (13709-329-01) / 2.5 g in 1 BLI... | Glycerin Laxative | Neilmed Pharmaceuticals Inc. | 2025-05-23 |
| 13709-0329-02 | 60 BLISTER PACK in 1 CARTON (13709-329-02) / 2.5 g in 1 BLI... | Glycerin Laxative | Neilmed Pharmaceuticals Inc. | 2025-05-23 |
| 13709-0329-03 | 120 BLISTER PACK in 1 CARTON (13709-329-03) / 2.5 g in 1 BL... | Glycerin Laxative | Neilmed Pharmaceuticals Inc. | 2025-05-23 |
| 37808-0398-50 | 50 SUPPOSITORY in 1 JAR (37808-398-50) | Glycerin | H E B | 2016-09-23 |
| 57237-0325-21 | 2 BLISTER PACK in 1 CARTON (57237-325-21) / 6 SUPPOSITORY i... | Glycerin | Rising Pharma Holdings, Inc. | 2023-08-24 |
| 57237-0325-52 | 5 BLISTER PACK in 1 CARTON (57237-325-52) / 5 SUPPOSITORY i... | Glycerin | Rising Pharma Holdings, Inc. | 2023-08-24 |
| 57237-0339-21 | 2 BLISTER PACK in 1 CARTON (57237-339-21) / 6 SUPPOSITORY i... | Proctozone GMax | Rising Pharma Holdings, Inc. | 2025-07-31 |
| 57237-0339-52 | 5 BLISTER PACK in 1 CARTON (57237-339-52) / 5 SUPPOSITORY i... | Proctozone GMax | Rising Pharma Holdings, Inc. | 2025-07-31 |
| 58980-0410-12 | 12 SUPPOSITORY in 1 JAR (58980-410-12) | Stratuscare Adult Glycerin | Stratus Pharmaceuticals | 2014-05-30 |
| 58980-0410-25 | 25 SUPPOSITORY in 1 JAR (58980-410-25) | Stratuscare Adult Glycerin | Stratus Pharmaceuticals | 2014-05-30 |
| 58980-0410-50 | 50 SUPPOSITORY in 1 JAR (58980-410-50) | Stratuscare Adult Glycerin | Stratus Pharmaceuticals | 2014-05-30 |
| 59779-0109-00 | 100 SUPPOSITORY in 1 JAR (59779-109-00) | CVS Pharmacy Glycerin Laxative | CVS Pharmacy | 2014-09-18 |
| 59779-0109-25 | 25 SUPPOSITORY in 1 JAR (59779-109-25) | CVS Pharmacy Glycerin Laxative | CVS Pharmacy | 2014-09-18 |
| 59779-0109-50 | 50 SUPPOSITORY in 1 JAR (59779-109-50) | CVS Pharmacy Glycerin Laxative | CVS Pharmacy | 2014-09-18 |
| 68016-0015-79 | 25 SUPPOSITORY in 1 JAR (68016-015-79) | Glycerin | Chain Drug Consortium LLC | 2012-03-15 |
| 68016-0015-80 | 50 SUPPOSITORY in 1 JAR (68016-015-80) | Glycerin | Chain Drug Consortium LLC | 2012-03-15 |
| 68016-0015-81 | 100 SUPPOSITORY in 1 JAR (68016-015-81) | Glycerin | Chain Drug Consortium LLC | 2012-03-15 |
| 69842-0724-10 | 100 SUPPOSITORY in 1 JAR (69842-724-10) | Glycerin | CVS Pharmacy | 2019-10-14 |
| 69842-0724-25 | 25 SUPPOSITORY in 1 JAR (69842-724-25) | Glycerin | CVS Pharmacy | 2019-10-14 |
| 69842-0724-50 | 50 SUPPOSITORY in 1 JAR (69842-724-50) | Glycerin | CVS Pharmacy | 2019-10-14 |
| 70000-0572-01 | 25 SUPPOSITORY in 1 JAR (70000-0572-1) | Glycerin | Cardinal Health | 2021-05-19 |
| 72701-0106-05 | 20 BLISTER PACK in 1 CARTON (72701-106-05) / 5 SUPPOSITORY... | Bliss GVS | Bliss GVS Pharma Limited | 2020-01-20 |
| 72701-0106-12 | 2 BLISTER PACK in 1 CARTON (72701-106-12) / 6 SUPPOSITORY i... | Bliss GVS | Bliss GVS Pharma Limited | 2020-01-20 |
| 72701-0106-25 | 5 BLISTER PACK in 1 CARTON (72701-106-25) / 5 SUPPOSITORY i... | Bliss GVS | Bliss GVS Pharma Limited | 2020-01-20 |
| 72701-0106-50 | 10 BLISTER PACK in 1 CARTON (72701-106-50) / 5 SUPPOSITORY... | Bliss GVS | Bliss GVS Pharma Limited | 2020-01-20 |
| 84415-0039-50 | 50 POUCH in 1 CARTON (84415-039-50) / 1 SUPPOSITORY in 1 PO... | Glycerin | Everpharm LLC | 2026-06-16 |
Observed labelers:
CVS Pharmacy (6) ·
Bliss GVS Pharma Limited (4) ·
C.B. Fleet Company, Inc. (4) ·
NeilMed Pharmaceuticals Inc. (4) ·
Rising Pharma Holdings, Inc. (4) ·
Rite Aid Corporation (4)
· +6 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.